Preferred Name |
aldesleukin |
|
Synonyms |
Proleukin |
|
ID |
http://purl.bioontology.org/ontology/MESH/C082598 |
|
altLabel |
Proleukin BAY 50-4798 2-133-Interleukin 2 (human reduced), 125-L-serine- |
|
cui |
C0701339 C0218986 C0971412 |
|
Has mapping qualifier | ||
HM |
D007376/Q000031 D011994 |
|
Inverse of RB |
M89N0Q7EQR |
|
isa | ||
LT |
TRD |
|
Mapped to | ||
MDA |
19930910 |
|
MeSH Frequency |
106 |
|
MMR |
20141022 |
|
notation |
C082598 |
|
PA |
D000970 D019380 |
|
prefLabel |
aldesleukin |
|
RR |
110942-02-4 (aldesleukin) |
|
SC |
1 |
|
Scope Statement |
a recombinant human IL-2, marketed for the treatment of metastatic renal cell carcinoma; BAY 50-4798 is a variant |
|
SRC |
Drug Ther Bull 1993 Apr 13;31(8):29-30 |
|
TERMUI |
T250043 T250042 T437437 |
|
TH |
US USAN (1990) MX UK NL CA NLM (2001) ES INN (19XX) AU FR |
|
tui |
T109 T116 T129 T121 |
Create mapping